Atrial flutter is a cardiac rhythm disorder characterized by rapid, coordinated contractions of the atria, the heart's upper chambers. Unlike atrial fibrillation, atrial flutter involves a well-organized and regular circuit of electrical signals in the heart. This abnormal rhythm can result from various factors, including heart disease, surgery, or lung conditions. Individuals with atrial flutter may experience symptoms such as a fluttering sensation in the chest, dizziness, or fainting. While atrial flutter is typically not immediately life-threatening, it can lead to complications such as blood clots and stroke. Diagnosis involves an electrocardiogram (ECG), and management may include medications to control heart rate and rhythm, as well as procedures like catheter ablation to correct the irregular electrical pathways. Early detection and appropriate intervention are essential in addressing atrial flutter and preventing potential complications.
Title : Personalized and precision medicine (PPM) as a unique healthcare model through biodesign-driven translational applications and cardiology-related healthcare marketing to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Beyond weight loss and diabetes control GLP 1 agonists paradigm shift in Cardiovascular care .
Syed Raza, Awali Hospital, Bahrain
Title : Vericiguat Inhibits the Progress of Cardiac Hypertrophy and Prevents Hypertrophy Induced Heart Failure by Multiple Mechanisms
Guo Wei He, TEDA International Cardiovascular Hospital, Tianjin University, China
Title : Coronary revascularization in patients with diabetes: Prospects for stenting in patients with type 1 diabetes and coronary artery disease
Mekhman N Mamedov, National Research Center for Therapy and Preventive Medicine, Russian Federation
Title : STEMI versus acute occlusive myocardial infarction: Which term should we use?
Yochai Birnbaum, Baylor College of Medicine, United States
Title : Chronic angina and the health economics of cardiovascular risk reduction in macro- and microvascular coronary disease
Uwe Peter Tigor, Auxilius Pharma, United States